Cargando…

Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections—A Cohort Study

BACKGROUND: The outcomes of hematogenous periprosthetic joint infection (PJI) and reasons for failure are largely unknown. METHODS: The outcomes of consecutive patients with hematogenous PJI treated at our institution between 2010 and 2019 were evaluated. Failure was classified as persistence or rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Renz, Nora, Trampuz, Andrej, Perka, Carsten, Rakow, Anastasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962703/
https://www.ncbi.nlm.nih.gov/pubmed/35355896
http://dx.doi.org/10.1093/ofid/ofac094
_version_ 1784677855069732864
author Renz, Nora
Trampuz, Andrej
Perka, Carsten
Rakow, Anastasia
author_facet Renz, Nora
Trampuz, Andrej
Perka, Carsten
Rakow, Anastasia
author_sort Renz, Nora
collection PubMed
description BACKGROUND: The outcomes of hematogenous periprosthetic joint infection (PJI) and reasons for failure are largely unknown. METHODS: The outcomes of consecutive patients with hematogenous PJI treated at our institution between 2010 and 2019 were evaluated. Failure was classified as persistence or relapse of infection or new infection. Failure-free survival was assessed using Kaplan-Meier analysis. Proportions between groups were compared with the Fisher exact test. RESULTS: One hundred thirty-two hematogenous PJI episodes involving knee (n = 76), hip (n = 54), shoulder (n = 1), or elbow (n = 1) prostheses experienced by 110 patients were included. The median follow-up (range) was 20.7 (0.2–89.9) months. Hematogenous PJIs were caused by Staphylococcus aureus (n = 49), Streptococcus spp. (n = 36), Enterococcus faecalis (n = 17), Enterobacterales (n = 16), coagulase-negative staphylococci (n = 9), and other (n = 6). Debridement and implant retention were performed in 50 (38%), prosthesis exchange or removal in 79 (60%), and no surgery in 3 episodes (2%). Treatment failed in 42 episodes (32%), including 6 infection-related deaths. Among 36 nonfatal failures, 21 were caused by a new pathogen and 8 by the same pathogen, in 7 episodes no pathogen was isolated. Of all nonfatal failures, 19 (53%) PJIs were of hematogenous origin. Identification of the primary focus, causative pathogen, and CRIME80 Score did not influence treatment outcome, but the failure rate was higher following prosthesis retention compared with multistage exchange. CONCLUSIONS: Persistence-/relapse-free survival after treatment of hematogenous PJI was high (84%). New hematogenous PJI due to the same or a new pathogen occurred frequently, reducing treatment success to 62% after 4 years of follow-up, suggesting an individual predisposition to hematogenous PJI. The outcome was similar for different pathogens but worse in episodes treated with prosthesis retention compared with multistage exchange.
format Online
Article
Text
id pubmed-8962703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89627032022-03-29 Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections—A Cohort Study Renz, Nora Trampuz, Andrej Perka, Carsten Rakow, Anastasia Open Forum Infect Dis Major Article BACKGROUND: The outcomes of hematogenous periprosthetic joint infection (PJI) and reasons for failure are largely unknown. METHODS: The outcomes of consecutive patients with hematogenous PJI treated at our institution between 2010 and 2019 were evaluated. Failure was classified as persistence or relapse of infection or new infection. Failure-free survival was assessed using Kaplan-Meier analysis. Proportions between groups were compared with the Fisher exact test. RESULTS: One hundred thirty-two hematogenous PJI episodes involving knee (n = 76), hip (n = 54), shoulder (n = 1), or elbow (n = 1) prostheses experienced by 110 patients were included. The median follow-up (range) was 20.7 (0.2–89.9) months. Hematogenous PJIs were caused by Staphylococcus aureus (n = 49), Streptococcus spp. (n = 36), Enterococcus faecalis (n = 17), Enterobacterales (n = 16), coagulase-negative staphylococci (n = 9), and other (n = 6). Debridement and implant retention were performed in 50 (38%), prosthesis exchange or removal in 79 (60%), and no surgery in 3 episodes (2%). Treatment failed in 42 episodes (32%), including 6 infection-related deaths. Among 36 nonfatal failures, 21 were caused by a new pathogen and 8 by the same pathogen, in 7 episodes no pathogen was isolated. Of all nonfatal failures, 19 (53%) PJIs were of hematogenous origin. Identification of the primary focus, causative pathogen, and CRIME80 Score did not influence treatment outcome, but the failure rate was higher following prosthesis retention compared with multistage exchange. CONCLUSIONS: Persistence-/relapse-free survival after treatment of hematogenous PJI was high (84%). New hematogenous PJI due to the same or a new pathogen occurred frequently, reducing treatment success to 62% after 4 years of follow-up, suggesting an individual predisposition to hematogenous PJI. The outcome was similar for different pathogens but worse in episodes treated with prosthesis retention compared with multistage exchange. Oxford University Press 2022-03-10 /pmc/articles/PMC8962703/ /pubmed/35355896 http://dx.doi.org/10.1093/ofid/ofac094 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Renz, Nora
Trampuz, Andrej
Perka, Carsten
Rakow, Anastasia
Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections—A Cohort Study
title Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections—A Cohort Study
title_full Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections—A Cohort Study
title_fullStr Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections—A Cohort Study
title_full_unstemmed Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections—A Cohort Study
title_short Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections—A Cohort Study
title_sort outcome and failure analysis of 132 episodes of hematogenous periprosthetic joint infections—a cohort study
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962703/
https://www.ncbi.nlm.nih.gov/pubmed/35355896
http://dx.doi.org/10.1093/ofid/ofac094
work_keys_str_mv AT renznora outcomeandfailureanalysisof132episodesofhematogenousperiprostheticjointinfectionsacohortstudy
AT trampuzandrej outcomeandfailureanalysisof132episodesofhematogenousperiprostheticjointinfectionsacohortstudy
AT perkacarsten outcomeandfailureanalysisof132episodesofhematogenousperiprostheticjointinfectionsacohortstudy
AT rakowanastasia outcomeandfailureanalysisof132episodesofhematogenousperiprostheticjointinfectionsacohortstudy